Quantcast

Latest Anti-diabetic medication Stories

2014-10-18 23:02:44

Another Actos Lawsuit Purports Patient Develop Bladder Cancer After Taking The Type Two Diabetes Medication Columbus, OH (PRWEB) October 18, 2014 Wright

2014-10-16 12:29:31

Prescribers Are Enthusiastic about the SGLT-2 Inhibitors, but Payers Are Not Fully Convinced of the Added Benefits of These Agents, According to Findings from Decision Resources Group BURLINGTON,

2014-10-08 23:01:34

The Firm is evaluating Byetta lawsuits and other legal claims that allege the use of diabetes drugs called incretin mimetics caused patients to develop pancreatic cancer, pancreatitis or thyroid

2014-10-08 16:26:22

Pegasus Legal Funding LLC Can Provide Financial Assistance to Those Adversely Affected NEW YORK, Oct.

2014-10-05 23:01:59

The Actos Lawsuit Purports Takeda Pharmceuticals Knew Long-Term Use Of The Medication Could Potentially Lead To Bladder Cancer. Columbus, OH (PRWEB) October

2014-10-03 16:24:45

Expresses Continued Confidence in ACTOS DEERFIELD, Ill., Oct. 3, 2014 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc.

2014-10-02 00:21:35

-FREEDOM-1 study showed that ITCA 650 demonstrated positive results when added to standard oral diabetes medications.

2014-09-30 23:00:28

Diabetes Miracle Cure reviews have been flooding the Internet and HealthyandFitZone.com reveals the truth about this method to cure diabetes permanently, without the need of using any outdated

2014-09-19 12:25:36

Culinary Expert Visits San Diego County on September 20 to Help Educate At-Risk Population About Ingredients for Successful Blood Sugar Management WHITEHOUSE STATION, N.J.,

2014-09-18 20:22:43

- Trulicity, a weekly glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for adults with type 2 diabetes as an adjunct to diet and exercise INDIANAPOLIS, Sept.